Drugs / BISMUTH SUBCITRATE
BISMUTH SUBCITRATE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00520949 | Oct 2006 → Jun 2008 | — | Aga Khan University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BISMUTH SUBCITRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1744033 ↗ |
| Known as | Cebes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00520949 ↗ |
| Known as | colloidal bismuth subcitrate | “Cebes (colloidal bismuth subcitrate)” NCT00520949 ↗ |
| Known as | Tripotassium dicitratobismuthate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1744033 ↗ |
| Modality | Small molecule | — CHEMBL1744033 ↗ |